EVH:NYE-Evolent Health Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 7.21

Change

0.00 (0.00)%

Market Cap

N/A

Volume

2.21M

Analyst Target

USD 11.67
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-24 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
DOCS Doximity Inc

N/A

USD 11.11B
WEAV Weave Communications Inc

N/A

USD 0.72B
AMWL American Well Corp

N/A

USD 0.11B
CTEV Claritev Corporation

N/A

N/A
HNGE Hinge Health, Inc.

N/A

N/A
PHR Phreesia Inc

N/A

N/A
TDOC Teladoc Inc

N/A

N/A
VEEV Veeva Systems Inc Class A

N/A

N/A
FOXO FOXO Technologies Inc.

N/A

N/A

ETFs Containing EVH

ACTV LeaderShares® Activist L.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -35.91% 25% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -35.91% 25% F 4% F
Trailing 12 Months  
Capital Gain -69.03% 13% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -69.03% 13% F 2% F
Trailing 5 Years  
Capital Gain -11.32% 75% C 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.32% 75% C 14% F
Average Annual (5 Year Horizon)  
Capital Gain 17.78% 80% B- 83% B
Dividend Return 17.78% 70% C- 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 61.23% 50% F 12% F
Risk Adjusted Return 29.04% 70% C- 47% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.